Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Historical Holders from Q4 2021 to Q1 2025

Symbol
XLO on Nasdaq
CUSIP
98422T100
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
48.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
25.8M
Holdings value
$24.7M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
34
Number of buys
10
Number of sells
-11
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GILEAD SCIENCES, INC. 19.9% $6.6M 9.11M GILEAD SCIENCES INC Dec 18, 2024
AbbVie Inc. 9% $3.15M 4.35M AbbVie Inc. Feb 11, 2025

Institutional Holders of Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 678K $491K +$7.44K $0.72 2
2024 Q4 25.8M $24.7M -$145K $0.96 34
2024 Q3 15.9M $12.5M +$1.13M $0.79 32
2024 Q2 13M $12.3M +$1.79M $0.95 30
2024 Q1 12.5M $13.5M -$2.78M $1.08 30
2023 Q4 15M $8.22M -$1.6M $0.55 32
2023 Q3 15.9M $33.5M -$315K $2.11 30
2023 Q2 16M $41.9M -$192K $2.62 32
2023 Q1 16.1M $51M +$462K $3.17 32
2022 Q4 15.9M $42.8M -$711K $2.69 28
2022 Q3 16.6M $48.2M -$3.74M $2.91 26
2022 Q2 17.8M $52M -$2.93M $2.92 26
2022 Q1 18.8M $133M -$2.57M $7.07 41
2021 Q4 19M $303M +$259M $16.00 41